다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Respiratory medicine case reports, v.30, 2020년, pp.101063 -
Horowitz, Richard I. (HHS Babesia and Tickborne Pathogen Subcommittee) , Freeman, Phyllis R. (Hudson Valley Healing Arts Center) , Bruzzese, James (Sophie Davis School of Biomedical Education)
AI-Helper
Abstract Purpose Infection with COVID-19 potentially can result in severe outcomes and death from “cytokine storm syndrome”, resulting in novel coronavirus pneumonia (NCP) with severe dyspnea, acute respiratory distress syndrome (ARDS), fulminant myocarditis and multiorgan dysfunction w...
1 Valencia Damian N. Brief review on COVID-19: the 2020 pandemic caused by SARS-CoV-2 Cureus 12 3 2020 https://www.cureus.com/articles/29459-brief-review-on-covid-19-the-2020-pandemic-caused-by-sars-cov-2
2 WHO Severe acute respiratory syndrome (SARS) WHO https://www.who.int/csr/sars/en/
3 Zaki A.M. van Boheemen S. Bestebroer T.M. Osterhaus A.D.M.E. Fouchier R.A.M. Isolation of a novel coronavirus from a man with pneumonia in Saudi arabia N. Engl. J. Med. 367 19 2012 1814 1820 10.1056/NEJMoa1211721 23075143
4 He F, Deng Y, Li W. Coronavirus disease 2019: what we know? J. Med. Virol . n/a(n/a). doi:10.1002/jmv.25766.
5 American Academy of Otolaryngology Head and Neck Surgery Coronavirus disease 2019: resources https://www.entnet.org/content/coronavirus-disease-2019-resources Published March 15, 2020. Accessed March 29, 2020
6 Zhang J.-J. Dong X. Cao Y.-Y. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China Allergy February 2020 10.1111/all.14238
7 Singhal T. A review of coronavirus disease-2019 (COVID-19) Indian J. Pediatr. 87 4 2020 281 286 10.1007/s12098-020-03263-6 32166607
8 Poyiadji N. Shahin G. Noujaim D. Stone M. Patel S. Griffith B. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features Radiology . March 2020 201187 10.1148/radiol.2020201187
9 van den Brand J.M. Smits S.L. Haagmans B.L. Pathogenesis of Middle East respiratory syndrome coronavirus J. Pathol. 235 2 2015 175 184 10.1002/path.4458 25294366
10 Vardavas C.I. Nikitara K. COVID-19 and smoking: a systematic review of the evidence Tob. Induc. Dis. 18 2020 10.18332/tid/119324
11 Shi Y. Yu X. Zhao H. Wang H. Zhao R. Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan Crit. Care 24 2020 10.1186/s13054-020-2833-7
12 Garg S. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 — COVID-NET, 14 States, March 1–30, 2020 MMWR Morb. Mortal. Wkly. Rep. 69 2020 10.15585/mmwr.mm6915e3
13 Zhou F. Yu T. Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet Lond Engl . March 2020 10.1016/S0140-6736(20)30566-3
14 Dietz W, Santos‐Burgoa C. Obesity and its implications for COVID-19 mortality. Obesity. n/a(n/a). doi:10.1002/oby.22818.
15 Huang C. Wang Y. Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet Lond Engl 395 10223 2020 497 506 10.1016/S0140-6736(20)30183-5
16 Dey S.K. Rahman M.M. Siddiqi U.R. Howlader A. Analyzing the epidemiological outbreak of COVID-19: a visual exploratory data analysis approach J Med Virol . March 2020 10.1002/jmv.25743
17 Coronavirus https://www.who.int/emergencies/diseases/novel-coronavirus-2019
18 Baud D. Qi X. Nielsen-Saines K. Musso D. Pomar L. Favre G. Real estimates of mortality following COVID-19 infection Lancet Infect. Dis. 2020 10.1016/S1473-3099(20)30195-X 0(0)
19 McMichael T.M. Currie D.W. Clark S. Epidemiology of covid-19 in a long-term care facility in king county, Washington N. Engl. J. Med. 2020 10.1056/NEJMoa2005412 0(0)
20 Ruan Q. Yang K. Wang W. Jiang L. Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Intensive Care Med . March 2020 10.1007/s00134-020-05991-x
21 Yang X. Yu Y. Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir Med 2020 10.1016/S2213-2600(20)30079-5 0(0)
22 Mehta P. McAuley D.F. Brown M. Sanchez E. Tattersall R.S. Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression Lancet 395 10229 2020 1033 1034 10.1016/S0140-6736(20)30628-0 32192578
23 Karakike E. Giamarellos-Bourboulis E.J. Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis Front. Immunol. 10 2019 10.3389/fimmu.2019.00055
24 Wang W. He J. puyi Lie The definition and risks of cytokine release syndrome-like in 11 COVID-19-infected pneumonia critically ill patients: disease characteristics and retrospective analysis Intensive Care and Critical Care Medicine 2020 10.1101/2020.02.26.20026989
25 Li X. Geng M. Peng Y. Meng L. Lu S. Molecular immune pathogenesis and diagnosis of COVID-19 J Pharm Anal March 2020 10.1016/j.jpha.2020.03.001
26 Gu J. Gong E. Zhang B. Multiple organ infection and the pathogenesis of SARS J. Exp. Med. 202 3 2005 415 424 10.1084/jem.20050828 16043521
27 Wong C.K. Lam C.W.K. Wu A.K.L. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome Clin. Exp. Immunol. 136 1 2004 95 103 10.1111/j.1365-2249.2004.02415.x 15030519
28 Zhang Y. Li J. Zhan Y. Analysis of serum cytokines in patients with severe acute respiratory syndrome Infect. Immun. 72 8 2004 4410 4415 10.1128/IAI.72.8.4410-4415.2004 15271897
29 Huppert L.A. Matthay M.A. Ware L.B. Pathogenesis of acute respiratory distress syndrome Semin. Respir. Crit. Care Med. 40 1 2019 31 39 10.1055/s-0039-1683996 31060086
30 Matthay M.A. Zemans R.L. The acute respiratory distress syndrome: pathogenesis and treatment Annu. Rev. Pathol. 6 2011 147 163 10.1146/annurev-pathol-011110-130158 20936936
31 Zhang Y. Xiao M. Zhang S. Coagulopathy and antiphospholipid antibodies in patients with covid-19 N. Engl. J. Med. 2020 10.1056/NEJMc2007575 0(0)
32 Tang N. Li D. Wang X. Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J. Thromb. Haemostasis 18 4 2020 844 847 10.1111/jth.14768 32073213
33 Pierrakos C. Karanikolas M. Scolletta S. Karamouzos V. Velissaris D. Acute respiratory distress syndrome: pathophysiology and therapeutic options J. Clin. Med. Res. 4 1 2012 7 16 10.4021/jocmr761w 22383921
34 Martin T.R. Lung cytokines and ARDS: roger S. Mitchell lecture Chest 116 1 Suppl 1999 2S 8S 10.1378/chest.116.suppl_1.2s 10424558
35 Wohlrab P. Kraft F. Tretter V. Ullrich R. Markstaller K. Klein K.U. Recent advances in understanding acute respiratory distress syndrome F1000Research 7 2018 10.12688/f1000research.11148.1
36 Windsor A.C. Mullen P.G. Fowler A.A. Sugerman H.J. Role of the neutrophil in adult respiratory distress syndrome Br. J. Surg. 80 1 1993 10 17 10.1002/bjs.1800800106 8428262
37 Gadek J.E. Pacht E.R. The interdependence of lung antioxidants and antiprotease defense in ARDS Chest 110 6 1996 273S 277S 10.1378/chest.110.6_Supplement.273S 8989164
38 von Bismarck P. Klemm K. García Wistädt C.-F. Winoto-Morbach S. Schütze S. Krause M.F. Selective NF-kappaB inhibition, but not dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model Pulm. Pharmacol. Therapeut. 22 4 2009 297 304 10.1016/j.pupt.2009.02.002
39 Gasparini C. Feldmann M. NF-κB as a target for modulating inflammatory responses Curr. Pharmaceut. Des. 18 35 2012 5735 5745 10.2174/138161212803530763
40 Khachigian L.M. Collins T. Fries J.W. N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo Am. J. Pathol. 151 5 1997 1225 1229 9358747
41 Zhang W.J. Frei B. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells FASEB J Off Publ Fed Am Soc Exp Biol 15 13 2001 2423 2432 10.1096/fj.01-0260com
42 Suzuki Y.J. Aggarwal B.B. Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells Biochem. Biophys. Res. Commun. 189 3 1992 1709 1715 10.1016/0006-291x(92)90275-p 1482376
43 Rahman A. Fazal F. Blocking NF-κB Proc. Am. Thorac. Soc. 8 6 2011 497 503 10.1513/pats.201101-009MW 22052926
44 Cho S. Urata Y. Iida T. Glutathione downregulates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells Biochem. Biophys. Res. Commun. 253 1 1998 104 108 10.1006/bbrc.1998.9697 9875227
45 Bernard G.R. Potential of N-acetylcysteine as treatment for the adult respiratory distress syndrome Eur. Respir. J. Suppl. 11 1990 496s 498s 2278610
46 Pacht E.R. Timerman A.P. Lykens M.G. Merola A.J. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome Chest 100 5 1991 1397 1403 10.1378/chest.100.5.1397 1935300
47 Wu G. Fang Y.-Z. Yang S. Lupton J.R. Turner N.D. Glutathione metabolism and its implications for health J. Nutr. 134 3 2004 489 492 10.1093/jn/134.3.489 14988435
48 Hüttenbrink K.-B. Hummel T. Berg D. Gasser T. Hähner A. Olfactory dysfunction: common in later life and early warning of neurodegenerative disease Dtsch Ärztebl Int. 110 1–2 2013 1 7 10.3238/arztebl.2013.0001 23450985
49 Lechien J.R. Chiesa-Estomba C.M. De Siati D.R. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study Eur Arch Otorhinolaryngol . April 2020 1 11 10.1007/s00405-020-05965-1
50 Horowitz RI, Freeman PR. Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1 . Int. J. Gen. Med. doi:10.2147/IJGM.S193608.
51 Horowitz R.I. Freeman P.R. Precision medicine: the role of the MSIDS model in defining, diagnosing, and treating chronic Lyme disease/post treatment Lyme disease syndrome and other chronic illness: Part 2 Healthcare 6 4 2018 129 10.3390/healthcare6040129
52 Clarkson T.W. Magos L. The toxicology of mercury and its chemical compounds Crit. Rev. Toxicol. 36 8 2006 609 662 10.1080/10408440600845619 16973445
53 Patrick L. Mercury toxicity and antioxidants: Part 1: role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity Altern Med Rev J Clin Ther 7 6 2002 456 471
54 Citera M, Freeman PR, Horowitz RI. Empirical validation of the Horowitz multiple systemic infectious disease syndrome questionnaire for suspected Lyme disease. Int. J. Gen. Med. doi:10.2147/IJGM.S140224.
55 Butler T. The jarisch-herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis Am. J. Trop. Med. Hyg. 96 1 2017 46 52 10.4269/ajtmh.16-0434 28077740
56 Negussie Y. Remick D.G. DeForge L.E. Kunkel S.L. Eynon A. Griffin G.E. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever J. Exp. Med. 175 5 1992 1207 1212 10.1084/jem.175.5.1207 1569394
57 Horowitz R.I. Effects of shifting the acid-base balance among Lyme patients during jarish herxheimer flares: a small prospective study 16th International Scientific Conference on Lyme Disease & Other Tick-Borne Disorders. H. Presented at the: June 2003 (Hartford CT)
58 Kerstholt M. Vrijmoeth H. Lachmandas E. Role of glutathione metabolism in host defense against Borrelia burgdorferi infection Proc. Natl. Acad. Sci. U. S. A. 115 10 2018 E2320 E2328 10.1073/pnas.1720833115 29444855
59 Horowitz R. How Can I Get Better?: an Action Plan for Treating Resistant Lyme & Chronic Disease 1 edition 2017 St. Martin’s Griffin New York, NY
60 Horowitz R. Why Can't I Get Better? Solving the Mystery of Lyme and Chronic Disease 1 edition 2013 St. Martin’s Press New York
61 Pan F. Ye T. Sun P. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia Radiology February 2020 200370 10.1148/radiol.2020200370 32053470
62 Shankar A.H. Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection Am. J. Clin. Nutr. 68 2 Suppl 1998 447S 463S 9701160
63 Prasad A.S. Beck F.W.J. Bao B. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress Am. J. Clin. Nutr. 85 3 2007 837 844 17344507
64 Prasad A.S. Bao B. Beck F.W.J. Kucuk O. Sarkar F.H. Antioxidant effect of zinc in humans Free Radic. Biol. Med. 37 8 2004 1182 1190 10.1016/j.freeradbiomed.2004.07.007 15451058
65 Hemilä H. Louhiala P. Vitamin C may affect lung infections J. R. Soc. Med. 100 11 2007 495 498 18048704
66 Hemilä H. Vitamin C and community-acquired pneumonia Am. J. Respir. Crit. Care Med. 184 5 2011 621 622 10.1164/ajrccm.184.5.621a 21885641
67 Do vitamins C and E affect respiratory infections? https://www.mv.helsinki.fi/home/hemila/thesis.htm
68 Shay K.P. Moreau R.F. Smith E.J. Smith A.R. Hagen T.M. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential Biochim. Biophys. Acta 1790 10 2009 1149 1160 10.1016/j.bbagen.2009.07.026 19664690
69 Zhang Q. Ju Y. Ma Y. Wang T. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia Medicine (Baltim.) 97 45 2018 10.1097/MD.0000000000013087
70 Soltan-Sharifi Mohammad Sadegh Mojtahedzadeh Mojtaba Najafi Atabak Reza Khajavi Mohammad Rouini Mohammad Reza Moradi Mandana Mohammadirad Azadeh Abdollahi Mohammad Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms https://journals.sagepub.com/doi/10.1177/0960327107083452 2007
71 Voskresenska N. Voicehovska J. Babikovs S. Glutathione level in community-acquired pneumonia patients Eur. Respir. J. 50 suppl 61 2017 10.1183/1393003.congress-2017.PA988
72 Kobayashi E.H. Suzuki T. Funayama R. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription Nat. Commun. 7 2016 10.1038/ncomms11624
73 Derosa G. Maffioli P. Simental-Mendía L.E. Bo S. Sahebkar A. Effect of curcumin on circulating interleukin-6 concentrations: a systematic review and meta-analysis of randomized controlled trials Pharmacol. Res. 111 2016 394 404 10.1016/j.phrs.2016.07.004 27392742
74 Yadav V.S. Mishra K.P. Singh D.P. Mehrotra S. Singh D.V.K. Immunomodulatory effects of curcumin Immunopharmacol. Immunotoxicol. 27 3 2005 485 497 10.1080/08923970500242244 16237958
75 Subedi L. Lee J.H. Yumnam S. Ji E. Kim S.Y. Anti-inflammatory effect of sulforaphane on LPS-activated microglia potentially through JNK/AP-1/NF-κB inhibition and Nrf2/HO-1 activation Cells 8 2 2019 10.3390/cells8020194
76 Lakkur S. Judd S. Bostick R.M. Oxidative stress, inflammation, and markers of cardiovascular health Atherosclerosis 243 1 2015 38 43 10.1016/j.atherosclerosis.2015.08.032 26343870
77 Siddiqui A. Desai N.G. Sharma S.B. Aslam M. Sinha U.K. Madhu S.V. Association of oxidative stress and inflammatory markers with chronic stress in patients with newly diagnosed type 2 diabetes Diabetes Metab Res Rev 35 5 2019 e3147 10.1002/dmrr.3147 30801898
78 Niki E. Lipid peroxidation products as oxidative stress biomarkers BioFactors Oxf Engl 34 2 2008 171 180
79 Rahman M.M. McFadden G. Modulation of NF-κB signalling by microbial pathogens Nat. Rev. Microbiol. 9 4 2011 291 306 10.1038/nrmicro2539 21383764
80 Abraham E. The dichotomy of inhibiting nuclear factor kappa-B in pneumonia Crit. Care 17 3 2013 152 10.1186/cc12722 23759070
81 Liu G. Park Y.-J. Tsuruta Y. Lorne E. Abraham E. p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury J Immunol Baltim Md 182 8 1950 5063 5071 10.4049/jimmunol.0803526 2009
82 Everhart M.B. Han W. Sherrill T.P. Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury J Immunol Baltim Md 176 8 1950 4995 5005 10.4049/jimmunol.176.8.4995 2006
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.